In endometrial cancer, biomarkers for preoperative identification of patients with low risk for disease progression would enable stratification according to the extent of surgery needed, and would avoid the complications that can be associated with radical surgery. A panel of proteins, amino acids, enzymes, and miRNA has been investigated as potential biomarkers for endometrial cancer. At the time of the manuscript submission targeted metabolomics/lipidomics approaches have not been applied to biomarker research in endometrial cancer. Using electrospray ionization-tandem mass spectrometry we quantified 163 metabolites in 126 plasma samples (61 patients with endometrial cancer, 65 control patients). Three single phosphatidylcholines were ide...
The present study was aimed at identifying novel proteins in endometrial cancer (EC), employing prot...
Endometrial cancer (EC) is the most common cancer of the female reproductive tract in developed coun...
Endometriosis is a complex, polygenic, and estrogen-dependent disease that affects 6% to 10% of wome...
Endometrial cancer is strongly associated with obesity and dysregulation of metabolic factors such a...
BACKGROUNDCurrent non-invasive diagnostic methods for endometriosis lack sensitivity and specificity...
Background: Endometrial cancer is strongly associated with obesity and dysregulation of metabolic fa...
Endometrial cancer (EC) is the most frequent gynecological cancer in developed countries. Most EC oc...
Metabolomic profiling analysis has the potential to highlight new molecules and cellular pathways th...
Endometrial cancer is the most common gynaecological malignancy in developed countries. Over 382,000...
Endometrial cancer (EC) is the most common gynecological neoplasm in high-income countries. Five-yea...
Endometrial cancer (EC) is the most common gynecological neoplasm in high-income countries. Five-yea...
Endometrial cancer arises from the endometrium. It has a slow progression and a reported survival ra...
The present study was aimed at identifying novel proteins in endometrial cancer (EC), employing prot...
Endometrial cancer (EC) is the most common cancer of the female reproductive tract in developed coun...
Endometriosis is a complex, polygenic, and estrogen-dependent disease that affects 6% to 10% of wome...
Endometrial cancer is strongly associated with obesity and dysregulation of metabolic factors such a...
BACKGROUNDCurrent non-invasive diagnostic methods for endometriosis lack sensitivity and specificity...
Background: Endometrial cancer is strongly associated with obesity and dysregulation of metabolic fa...
Endometrial cancer (EC) is the most frequent gynecological cancer in developed countries. Most EC oc...
Metabolomic profiling analysis has the potential to highlight new molecules and cellular pathways th...
Endometrial cancer is the most common gynaecological malignancy in developed countries. Over 382,000...
Endometrial cancer (EC) is the most common gynecological neoplasm in high-income countries. Five-yea...
Endometrial cancer (EC) is the most common gynecological neoplasm in high-income countries. Five-yea...
Endometrial cancer arises from the endometrium. It has a slow progression and a reported survival ra...
The present study was aimed at identifying novel proteins in endometrial cancer (EC), employing prot...
Endometrial cancer (EC) is the most common cancer of the female reproductive tract in developed coun...
Endometriosis is a complex, polygenic, and estrogen-dependent disease that affects 6% to 10% of wome...